Cal/BDP combination

DRUG3 trials

Sponsors

MC2 Therapeutics

Conditions

Psoriasis Vulgaris

Phase 2

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

CompletedNCT03462927

MC2 TherapeuticsPsoriasis Vulgaris

Start: 2018-02-08End: 2018-08-04Updated: 2019-12-24

Phase 3

A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

CompletedNCT03308799

MC2 TherapeuticsPsoriasis Vulgaris

Start: 2017-10-03End: 2018-06-08Updated: 2024-12-09

This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream

CompletedNCT03802344

MC2 TherapeuticsPsoriasis Vulgaris

Start: 2018-12-12End: 2019-10-02Updated: 2020-12-16

Related Papers

Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials.

2025-04-24

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

Dermatology and Therapy2023-07-253 citations

Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis

Journal of Drugs in Dermatology2023-06-014 citations

A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30<sup>th</sup> EADV Congress 2021.

2023-01-014 citations

Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application.

2022-09-0118 citations

Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.

PubMed2022-03-017 citations

Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS).

2021-10-146 citations

A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.

PubMed2021-04-0111 citations

A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream

Journal of Drugs in Dermatology2021-03-0121 citations